On October 7, 2013, each of George W. Hebard III and Richard A. Young informed Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE